Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

TRACON Pharmaceuticals, Inc.

NASDAQ: TCONHealthcare / Biotechnology / USA
0.9600-0.1000-9.43%Vol 554 4291Y Perf -68.52%
Jan 18th, 2019 16:00
BID0.9600 ASK1.00
Open1.04 Previous Close1.06
Pre-Market1.03 After-Trading1.00
 -0.03 -2.83%  0.04 4.17%
Target Price
2.70 
Analyst Rating
Moderate Buy 2.00
Potencial %
181.25 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
★+     41.13
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)29 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
17.04 
Earnings Date
27th Feb 2019

Today's Price Range

0.91001.14

 

52wk Range

0.50003.20

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Neutral
Performance
1 Month
-8.57%
3 Months
-36.42%
6 Months
-62.35%
1 Year
-68.52%
3 Years
-86.85%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
TCON0.9600-0.1000-9.43
AAPL156.820.96000.62
GOOG1 098.268.36000.77
MSFT107.711.59001.50
XOM72.990.86001.19
WFC50.010.78001.58
JNJ130.691.60001.24
FB150.041.74001.17
GE9.06-0.0800-0.88
JPM104.591.67001.62
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
3.50
Current Ratio
3.60
Long Term Debt to Total Capital
0.17
Total Debt to Equity
0.22
Interest Coverage
-164.50
Leverage Ratio 1.50
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
-
EBIT Margin
-1 111.60
EBITDA Margin
-1 110.60
Pre-tax Profit Margin
-343.50
Profit Margin
-
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
0.86
PS Ratios
8.16
Price to Cash Flow
74.30
Price to Free Cash Flow
-1.10
Cash Flow Per Share
-1.05
Price to Tangible Book
0.86
Book Value per Share
0.96
Enterprise Value (in ths.)
-16 334
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
381.00
ROE last 12 Months
-134.05
Return on Assets (5Y Avg)
-39.88
ROA last 12 Months
-78.64
Return on Capital (5Y Avg)
-
ROC last 12 Months
-105.44
Return on invested Capital Q
-23.12
Return on invested Capital Y
-63.44
Assets Turnover
0.00
Receivables Turnover
-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
3 000
Revenue per Share
0.10
Revenue Growth 3 Years
-15.78
Revenue Growth 5 Years
-
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q03 2018-0.27-0.30-11.11
Q02 2018-0.30-0.33-10.00
Q01 2018-0.33-0.46-39.39
Q04 2017-0.45-0.3717.78
Q03 2017-0.250.07128.00
Q02 2017-0.53-0.4024.53
Q01 2017-0.47-0.446.38
Q04 2016-0.45-0.450.00
Earnings Per EndEstimateRevision %Trend
12/2018 QR-0.38-65.22Negative
12/2018 FY-1.44-17.07Negative
3/2019 QR-0.17-70.00Negative
12/2019 FY-0.47-38.24Negative
Next Report Date27th Feb 2019
Estimated EPS Next Report-0.38
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume554 429
Shares Outstanding (in ths.)29 871
Trades Count727
Dollar Volume547 427
Avg. Volume415 618
Avg. Weekly Volume605 647
Avg. Monthly Volume543 477
Avg. Quarterly Volume277 280

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

46%54%

Bearish Bullish

59%41%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (50.00 %)
1 (50.00 %)
1 (50.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (50.00 %)
1 (50.00 %)
1 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
2.00
Moderate Buy
2.00
Moderate Buy
2.00

There are no comments yet.

News